The University of Chicago’s Microbiome Research Symposium last month brought together experts from UChicago, Argonne National Laboratory and the Marine Biological Laboratory to meet with students, postdoctoral scholars and early-career scientists. Participants shared their insights into the human microbiome and its possibilities in treating disease.
The discussions focused on emerging and essential microbial methods.
Speakers included keynote Libusha Kelly, PhD, from the Albert Einstein College of Medicine in New York; Magdalena “Maggie” Osburn at Northwestern University; A. Murat Eren, an assistant professor at UChicago’s Department of Medicine and a fellow at the Marine Biological Laboratory; and Laura Sanchez, an assistant professor in medicinal chemistry and pharmacognosy at the University of Illinois at Chicago.
A panel discussion hosted by the Polsky Center for Entrepreneurship and Innovation titled “Idea to Impact: Experiences in Commercialization of Microbiome Discoveries,” featured business leaders for startups AVnovum, Covira Surgical and Seurat Therapeutics, explaining how they have leveraged Polsky’s resources to develop potentially lifesaving medical breakthroughs.